These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8072183)

  • 1. [Clinical efficacy of arbekacin on MRSA pneumonia].
    Kawashima T; Shishibara T; Nakamura H; Kuriyama T; Kanno S; Watanabe M; Kikuchi N; Kunitomo F; Yamagishi F; Mizutani F
    Jpn J Antibiot; 1994 Jun; 47(6):741-50. PubMed ID: 8072183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
    Odagiri S; Sumitomo M; Takahashi K; Matsumoto F; Sakurai I; Imai T; Yoshikawa K; Ito A; Sugiyama M; Suzuki M
    Jpn J Antibiot; 1994 Jun; 47(6):751-62. PubMed ID: 8072184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of arbekacin on MRSA infections].
    Ichiyama S; Shimokata K
    Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK].
    Arakawa M; Wada K; Sega H; Yoshikawa H; Honma T; Miyao H; Shimazu Y; Tsukada H; Hoshino S; Sato S
    Jpn J Antibiot; 1994 Jun; 47(6):736-40. PubMed ID: 8072182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
    Ochiai M; Tanimura H; Noguchi K; Takifuji K; Konishi R; Ohkouchi N; Kouno N; Ohnishi H; Shimada K; Kasitani M
    Jpn J Antibiot; 1994 Jun; 47(6):837-43. PubMed ID: 8072194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
    Hayashi I; Inoue M; Hashimoto H
    Jpn J Antibiot; 1994 Jun; 47(6):595-605. PubMed ID: 8072167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
    Kuwabara M; Konishi F; Yokoyama T; Kodama T; Santoh T; Nakai S; Miyoshi N; Kurimura T; Miyazawa T; Arita K
    Jpn J Antibiot; 1994 Jun; 47(6):771-80. PubMed ID: 8072186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
    Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
    Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
    Hamazaki H; Horiuchi A; Hasegawa H; Masaoka T; Kitani T; Kanayama Y; Sugiyama H; Tatsumi N; Kageyama T; Uchino H
    Jpn J Antibiot; 1994 Jun; 47(6):763-70. PubMed ID: 8072185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
    Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
    Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
    Hayashi I; Inoue M; Hashimoto H
    Drugs Exp Clin Res; 1994; 20(6):225-32. PubMed ID: 7758394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man].
    Totsuka K; Shimizu K; Mitomi N; Niizato T; Araake M
    Jpn J Antibiot; 1994 Jun; 47(6):676-92. PubMed ID: 8072176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
    Matsumoto T; Hanaki H; Kimura T; Nemoto M; Higashihara M; Yokota H; Oda S; Akiyama N; Miyao N; Yoshida M; Yukioka T; Soma K; Ohyashiki K; Suzuki Y; Arai T; Ikegami K; Ichiwata T; Otsuka Y; Kobayashi M; Totsuka K; Sunakawa K;
    J Infect Chemother; 2013 Feb; 19(1):128-37. PubMed ID: 23263188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage regimen of arbekacin for methicillin-resistant Staphylococcus aureus infection in newborns and infants.
    Yoshida K; Minowa H; Ebisu R; Uchida Y; Takahashi Y; Yoshioka A
    Pediatr Int; 2004 Dec; 46(6):645-9. PubMed ID: 15660861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
    Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
    Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
    Tanaka T; Iida-Tanaka K; Takahara J; Fujioka Y; Tamura T; Yamanoi Y; Houjou S; Takahashi T; Miki S; Nakamura Y
    Jpn J Antibiot; 1994 Jun; 47(6):790-7. PubMed ID: 8072188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of arbekacin for staphylococcal infection in the NICU.
    Suzuki K
    Pediatr Int; 2003 Jun; 45(3):301-6. PubMed ID: 12828585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.